On February 11, 2019 Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, reported that it is scheduled to participate in a panel at the Innovation for Health 2019 Conference and Global Investor Forum on Thursday, February 14, 2019 (Press release, Kiadis, FEB 11, 2019, View Source [SID1234533321])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Innovation for Health
February 14, 2019, World Trade Center Rotterdam, Beursplein 37, Rotterdam, The Netherlands
Arthur Lahr, Chief Executive Officer, will participate in a panel discussion related to "Building a Winning Team for Innovation" held from 13:30 – 14:30 CET.

Innovation for Health is one of the premier events for Health & Life Sciences in the Netherlands and Belgium. It brings together key players in health and care, from bench to boardroom, start-up to multinational and from life sciences to medtech. Held in conjunction with Global Investor Forum, Innovation for Health brings together over 800 delegates and 60 influential speakers from across industry, academia, government, finance and patient-organisations with the purpose to contribute to a sustainable future of healthcare.